Phase II trial of weekly or bi-weekly tocilizumab with ipilimumab and nivolumab in advanced melanoma: Clinical outcomes and biomarker analysis Article

Web of Science: 001275557402241

Cited authors

  • Anouti B, McVay K, Abraham M, Johnson DH, Amaria RN, Spillson C, Glitza IC, Patel SP, Wong MKK, McQuade JL, Tawbi HA, Davies MA, Ikeguchi A, Bentebibel SE, Abdel-Wahab R, Elsayes KM, Allison JP, Sharma P, Abdel-Wahab N, Diab A

Authors

Publication date

  • 2024

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Number of pages

  • 1

Volume

  • 42

Issue

  • 16